Table 2.
Exhaustion Marker Expressed on T Cell | Ligand | Cells Expressing the Ligand | Influence on Antitumor Functions of T Cells |
---|---|---|---|
PD-1 | PD-L1 | Tumor cells, DCs, TAMs, Bregs | Inhibitory |
CTLA-4 | CD80/CD86 | DCs, B cells, TAMs, Treg | Inhibitory |
TIM3 | Galectin 9 | APC | Both inhibitory and activating, but mostly inhibitory |
LAG3 | MHC-I or MHC-II–Peptide complex | APC, tumor cells | Both inhibitory and activating, but mostly inhibitory |
TIGIT | CD155 | APC | Inhibitory |
Vista | ? | APC | Largely remains to be elucidated |
CD96 | CD112 | APC, tumor cells | Largely remains to be elucidated |
BTLA-4 | HVEM | T cells, Tregs, APCs, tumor cells | Largely remains to be elucidated |
CD160 | HVEM | T cells, Tregs, APCs, tumor cells | Largely remains to be elucidated |